Kuritzkes, D R <br/><br/>
Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients.  [electronic resource] 

 -  AIDS (London, England)  Aug 1996 
 - 975-81 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0269-9370 
<br/><br/><label>Standard No.: </label>10.1097/00002030-199610090-00007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--pharmacology<br/>Double-Blind Method<br/>Drug Resistance<br/>Drug Therapy, Combination<br/>Female<br/>Genes, Viral<br/>HIV Infections--drug therapy<br/>HIV-1--drug effects<br/>Humans<br/>Lamivudine--pharmacology<br/>Male<br/>Mutation--drug effects<br/>Virus Replication<br/>Zidovudine--pharmacology